apl. Prof. Dr. Ursula Schlötzer-Schrehardt

Medizinische Fakultät

The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome (2019) Berner D, Hoja U, Zenkel M, Ross JJ, Uebe S, Paoli D, Frezzotti P, et al. Journal article Imbalances in protein homeostasis caused by mutant desmin (2019) Winter L, Unger A, Berwanger C, Spörrer M, Türk M, Chevessier F, Strucksberg KH, et al. Journal article Functional implication of the pseudoexfoliation-associated rare variant p.Y407F at LOXL1 (2019) Berner D, Hoja U, Zenkel M, Pasutto F, Lee MC, Aung T, Khor CC, et al. Conference contribution Involvement of caspase 7 in the excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy (2019) Tonomura S, Okumura N, Endo M, Nakahara M, Tourtas T, Schlötzer-Schrehardt U, Kruse F, Koizumi N Conference contribution Potential functional restoration of corneal endothelial cells in Fuchs corneal dystrophy by ROCK inhibitor (Ripasudil) (2019) Kruse F, Tourtas T, Zenkel M, Kinoshita S, Schlötzer-Schrehardt U Conference contribution Involvement of a disintegrin and metalloproteinase 10 (ADAM10) in excessive extracellular matrix production in Fuchs endothelial corneal dystrophy (2019) Komori Y, Okumura N, Hanada N, Tokunaga A, Tourtas T, Schlötzer-Schrehardt U, Kruse F, Koizumi N Conference contribution Identifying Genes that Underlie Exfoliation Syndrome using Genetically Determined Gene Expression (2019) Hirbo J, Pasutto F, Pawar P, Sealock J, Evans P, Gamazon E, Tao R, et al. Conference contribution Are agonistic beta 2-adrenergic receptor autoantibodies present in normal tension glaucoma and secondary open-angle glaucoma? (2019) Hohberger B, Mardin CY, Hosari S, Lämmer R, Kunze R, Juenemann A, Schlötzer-Schrehardt U, et al. Conference contribution Feasibility of mTOR inhibitor for the treatment of Fuchs endothelial corneal dystrophy (2019) Nakayama G, Okumura N, Oshima T, Ueda E, Watanabe K, Tourtas T, Schlötzer-Schrehardt U, et al. Conference contribution Drug discovery for the treatment of Fuchs corneal endothelial dystrophy by cell-based drug screening system (2019) Nakagawa R, Okumura N, Onishi T, Oshima T, Ueda E, Watanabe K, Tourtas T, et al. Conference contribution